W
ounds and particularly chronic wounds are major concerns for the patient and clinician alike; chronic wounds affect a large number of patients and seriously reduce their quality of life. Current estimates indicate that nearly 6 million people suffer from chronic wounds worldwide. There are very few Indian studies on the epidemiology of chronic wounds. In one study, the prevalence of chronic wounds in the community was reported as 4.5 per 1000 population whereas that of acute wounds was nearly doubled at 10.5 per 1000 population. 1 The causes for chronic wounds are many, including such systemic conditions as diabetes mellitus, atherosclerosis, tuberculosis, and leprosy. Other major causes include venous ulcers, pressure sores, and trauma vasculitis. Such conditions as tuberculosis and leprosy, which are uncommon in Western societies, are often encountered in India. However, diabetic foot ulcers are an extremely common clinical condition encountered in Varanasi, India, similar to that seen in the Western population. In the above-referenced study, inadequate and inappropriate treatment of acute wounds was the commonest cause of chronic wounds. The practice of walking and working barefoot especially in the agricultural fields also contributed as causes. This unequivocally underscores the importance of conceptualizing and implementing quality wound care programs at the community level. Needless to say, these programs imply a multidisciplinary approach composed of a dedicated group of wound care health personnel including wound care nurses. In India, the problem of chronic wounds is compounded by other demographic factors such as low literacy rates, poor access to health care, lack of adequate manpower, and inadequate health infrastructure.
The other major area of concern for wound care physicians is a limited knowledge of the physiological processes involved in wound healing. The field of wound healing and tissue regeneration represents a tremendously diverse area of clinical and scientific activity encompassing the most basic of wound care therapies to the most advanced analysis of cellular regulatory mechanisms. Chronic wounds, burns, and scars are complex, they have many causes, and they affect patients in many different ways. As a result, they can only be understood using a broad range of scientific and medical disciplines. Chronic wounds afflict a very large number of patients and seriously reduce their quality of life. Why some wounds heal in a reasonable time frame whereas others do not is something that we still do not understand despite the almost limitless scientific advances in the past few decades. The physiology of wound healing should be a major area of focus for ongoing scientific research. At present, there is a multitude of therapeutic approaches for the management of chronic wounds. Many of these are driven by industry, and the actual benefits of these treatment protocols are yet to be published.
In the past, not much attention was devoted to chronic wounds, as the federal governments, the private sector, and the medical community were slow to focus on this growing health care problem. But with the rising elderly population and the increasing incidence of diabetes, the care of these wounds is fast becoming a billion-dollar business. Treatments that exist today, however, are often expensive and often not reimbursed through medical insurance. Current efforts in woundhealing research are directed toward developing new methods for promoting wound closure to be used alongside the traditional approaches of debridement and infection control. The most important of these innovations includes the use of skin substitutes and biomolecules that stimulate skin repair. Future research may identify targets for newer therapies. The Wound Management Research Team a should be a multidisciplinary team composed of laboratory scientists as well as medical and clinical specialists. The development of a new therapy by the research team would involve various considerations such as the efficacy of the product, its side effects, the health economics, marketing of strategies, and above all the cost-benefit analysis. It is thus imperative that the research team must develop a network of contacts and collaborations with academic and clinical specialists worldwide. It should be borne in mind that the new product should be easy to manufacture and clinically efficacious, and regulatory bodies should permit the product to be marketed with reimbursement from medical insurance. This will allow the research team to select the right projects that have the maximum chance of clinical and commercial success.
Some of the promising research areas include
• ways in which the chronic wound bed may be prepared, so that it better resembles an acute wound • therapies that increase blood flow to the wound bed, because blood supplies the oxygen and nutrients needed for wound healing • restoration of normal cell behavior in the wound bed, by using the properties of healthy cells to stimulate and govern the healing process • designing and testing biomaterials that support tissue repair, so that cells can occupy and repair the wound more easily • investigation of the role that bacteria play in impeding wound healing and work to reduce bacteria and to control their behaviors • searches for solutions that remove detrimental components that build up in a chronic wound and its wound fluid while maintaining all useful factors in the wound • finding ways to intervene in the pathological processes that lead to a chronic wound • seeking to make new and existing therapies more effective, easier to use, and more acceptable for patients
With this perspective, it is fairly obvious that state funding for wound research is unlikely to be forthcoming because (1) resources are limited and (2) it is a lowpriority area. The gap between the expectation and the delivery has to be bridged by the pharmaceutical industry. An essential caveat to this premise is that the industry must understand that a very large part of the funding would be consumed by research that may not yield the expected dividends. However, given the magnitude of the problem, industry will benefit in the long run. It is important to realize that public-private partnerships though difficult to formulate appear to be the only way forward in providing quality wound care to the millions of afflicted individuals.
